Neurorecovery

NeuroRecovery Technologies is a medical technology company focused on developing restorative therapies for patients with paralysis due to spinal cord injuries. The company utilizes neuromodulation techniques, specifically transcutaneous and epidural spinal cord stimulation, to re-engage dormant neural circuits below the site of injury. Their technology aims to improve motor function, autonomic control, and overall quality of life for individuals with chronic spinal cord damage. Founded by leading neuroscientists from UCLA and EPFL, the company's approach is rooted in decades of research into spinal cord plasticity. In 2019, the company merged with GTX Medical to form Onward Medical, which is currently advancing these therapies through pivotal clinical trials.